Corporate News

MyHealthChecked PLC (AIM: MHC), the consumer home-testing healthcare company, announces that it has signed a supply agreement with Boots UK Ltd ("Boots") to supply a range of lateral flow self-tests and laboratory tests under the Boots' Own Brand label.

The contract, with an initial term of 12 months, covers a range comprising eight blood tests, one DNA test, and four lateral flow self-tests, which will be launched by Boots in August 2025.

Penny McCormick, Chief Executive Officer of MyHealthChecked PLC, said: "We're delighted to have secured this supply into Boots in the expansion of its range of own brand wellness tests. We have developed a strong working and commercial relationship with Boots over the past four years, and we're excited to see this continue."

For further information contact:

About MyHealthChecked PLC (www.myhealthcheckedplc.com)

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.

MyHealthChecked is the umbrella brand of a range of at-home rapid tests, as well as DNA, RNA and blood sample collection kits which have been created to support customers on their journeys to wellness. The tests are lateral-flow self-tests, whilst the sample collection kits enable the collection of blood, urine, nasal or mouth swab samples that are analysed in partner laboratories for a range of biomarkers. The tests have been made available online and for over-the-counter purchase. 

The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.